Deep vein thrombosis in patients with multiple myeloma treated with thalidomide and chemotherapy: effects of prophylactic and therapeutic anticoagulation-Reference-Cited by-同舟云学术

Deep vein thrombosis in patients with multiple myeloma treated with thalidomide and chemotherapy: effects of prophylactic and therapeutic anticoagulation

Published:2004-07-29 Issue:5 Volume:126 Page:715-721
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:

Author:

Zangari Maurizio,Barlogie Bart,Anaissie Elias,Saghafifar Fariba,Eddlemon Paul,Jacobson Joth,Lee Choon-Kee,Thertulien Raymond,Talamo Giampaolo,Thomas Teri,Rhee Frits Van,Fassas Athanasios,Fink Louis,Tricot Guido

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2141.2004.05078.x/fullpdf

Reference16 articles.

1. Prevention of venous thromboembolism in medical patients with enoxaparin: a subgroup analysis of the MEDENOX study;Alikhan;Blood Coagulation Fibrinolysis,2003

2. Venous thromboembolism and cancer;Baron;Lancet,1998

3. Cancer and thrombosis;Donati;Haemostasis,1994

4. Estimation of failure probabilities in the presence of competing risks: new representations of old estimators;Gooley;Statistics in Medicine,1999

5. Incidence of recurrent thromboembolic and bleeding complications among patients with venous thromboembolism in relation to both malignancy and achieved international ratio: a retrospective analysis;Hutten;Journal of Clinical Oncology,2000

Cited by 191 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Thromboprophylaxis in multiple myeloma: a case-based review with practical guidelines;Annals of Hematology;2024-04-17

2. Risk of thromboembolic events associated with different multiple myeloma regimens in Taiwan: a nested case-control study;Journal of Thrombosis and Thrombolysis;2023-09-22

3. Thrombosis in multiple myeloma: mechanisms, risk assessment and management;Leukemia & Lymphoma;2023-08-16

4. Abnormal metaphase cytogenetics predicts venous thromboembolism in myeloma: derivation and validation of the PRISM score;Blood;2022-12-08

5. Drug Targeting and Conventional Treatment of Multiple Myeloma: Analysis of Target-specific Nanotherapies in Disease Models;Current Drug Therapy;2022-10